The Ohio Department of Health and the Ohio Hospital Association will distribute remdesivir, an unproven antiviral treatment for COVID-19.
The medication was received from the U.S. Food and Drug Adminstration Tuesday. Ohio has received an allotment of 20 cases for 100 patients. The drug will be distributed to the geographic zones created to help Ohio with the pandemic response. In clinical trials, remdesivir has been found to shorten the duration of COVID-19 from 15 to 11 days in patients being treated in hospital settings.